Cargando…
Novel targets for immunotherapy in glomerulonephritis
Glomerulonephritis is a common cause of chronic kidney disease and end stage renal failure. Current therapy relies on variably effective, nonspecific and toxic immunosuppression. Recent insights into underlying biology and disease pathogenesis in human glomerulonephritis combined with advances in th...
Autor principal: | Foster, Mary H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721381/ https://www.ncbi.nlm.nih.gov/pubmed/19707383 |
Ejemplares similares
-
Glomerulonephritis: immunopathogenesis and immunotherapy
por: Anders, Hans-Joachim, et al.
Publicado: (2023) -
Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis
por: Shah, H. H., et al.
Publicado: (2017) -
Membranoproliferative glomerulonephritis
por: Alchi, Bassam, et al.
Publicado: (2009) -
Hypertension in Chronic Glomerulonephritis
por: Ihm, Chun-Gyoo
Publicado: (2015) -
Fibrillary Glomerulonephritis: An Update
por: Rosenstock, Jordan L., et al.
Publicado: (2019)